Company Filing History:
3 out of 26 
1 out of 3 Years Active: 2019-2021
Title: Ewa Witkowska: Innovator in Peptidomimetics
Introduction
Ewa Witkowska is a prominent inventor based in Zielonka, Poland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel peptidomimetics. With a total of three patents to her name, her work focuses on innovative solutions for treating various medical conditions.
Latest Patents
One of her latest patents is titled "Hybrid peptidomimetics for use in neuropathic pain." This invention pertains to novel hybrid peptidomimetics, which include a pharmaceutical composition designed for the treatment of neuropathic pain. The unique structure of these compounds consists of an opioid receptor agonist and a MC4 receptor antagonist, connected by a linker. This innovative design allows for the activation of opioid receptors while simultaneously blocking melanocortin type 4 receptors, thereby enhancing the efficacy of opioid therapy in managing neuropathic pain.
Another significant patent is "Cyclic peptidomimetics, compositions containing them and their use in the treatment of diseases associated with angiogenesis." This invention relates to novel cyclic peptidomimetics and their pharmaceutical compositions, aimed at treating diseases linked to angiogenesis, such as tumors and chronic inflammation in conditions like psoriasis, diabetes, degenerative diseases of the eye, nephropathy, and neuropathy.
Career Highlights
Ewa Witkowska has had a distinguished career, working with esteemed institutions such as the University of Warsaw and the Institute of Pharmacology of the Polish Academy of Sciences. Her research has significantly advanced the understanding and treatment of complex medical conditions through innovative pharmaceutical solutions.
Collaborations
Ewa has collaborated with notable colleagues, including Dagmara Tymecka and Bartlomiej Fedorczyk, contributing to her success in the field of pharmaceutical research.
Conclusion
Ewa Witkowska's innovative work in the development of peptidomimetics showcases her dedication to advancing medical science. Her patents reflect a commitment to improving treatment options for patients suffering from various ailments.